{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:57:02Z","timestamp":1769302622176,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10157-025-02692-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:15:05Z","timestamp":1747926905000},"page":"1627-1636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic value of serum hepcidin-25 in predicting cardiovascular events among maintenance hemodialysis patients: insights from the INFINITY cohort"],"prefix":"10.1007","volume":"29","author":[{"given":"Tomomi","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoe","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yasuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinami","family":"Nagura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Tsunemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-0374","authenticated-orcid":false,"given":"Hiroki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"11","key":"2692_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34(11):1803\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfz174.","journal-title":"Nephrol Dial Transplant"},{"issue":"9981","key":"2692_CR2","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(14)61601-9.","journal-title":"Lancet"},{"issue":"12 Suppl","key":"2692_CR3","first-page":"S16","volume":"9","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16-23.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2692_CR4","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.ekir.2021.07.032","volume":"6","author":"JB Wish","year":"2021","unstructured":"Wish JB, Anker SD, Butler J, Cases A, Stack AG, Macdougall IC. Iron deficiency in CKD without concomitant anemia. Kidney Int Rep. 2021;6(11):2752\u201362. https:\/\/doi.org\/10.1016\/j.ekir.2021.07.032.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2692_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ckj\/sfaa212","volume":"14","author":"L Del Vecchio","year":"2021","unstructured":"Del Vecchio L, Ekart R, Ferro CJ, Malyszko J, Mark PB, Ortiz A, et al. Intravenous iron therapy and the cardiovascular system: risks and benefits. Clin Kidney J. 2021;14(4):1067\u201376. https:\/\/doi.org\/10.1093\/ckj\/sfaa212.","journal-title":"Clin Kidney J"},{"key":"2692_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/asheducation-2011.1.538","volume":"2011","author":"T Ganz","year":"2011","unstructured":"Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematol Am Soc Hematol Educ Program. 2011;2011:538\u201342. https:\/\/doi.org\/10.1182\/asheducation-2011.1.538.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5704","key":"2692_CR7","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090\u20133. https:\/\/doi.org\/10.1126\/science.1104742.","journal-title":"Science"},{"issue":"6","key":"2692_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2215\/CJN.05931108","volume":"4","author":"J Zaritsky","year":"2009","unstructured":"Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, et al. Hepcidin\u2013a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1051\u20136. https:\/\/doi.org\/10.2215\/CJN.05931108.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2692_CR9","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/ndt\/gfq760","volume":"26","author":"T Kuragano","year":"2011","unstructured":"Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, et al. Hepcidin as well as TNF-\u03b1 are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2011;26(8):2663\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfq760.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2692_CR10","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","volume":"28","author":"NC van der Weerd","year":"2013","unstructured":"van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, et al. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant. 2013;28(12):3062\u201371. https:\/\/doi.org\/10.1093\/ndt\/gfs488.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2692_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5527\/wjn.v2.i2.38","volume":"2","author":"YP Hsieh","year":"2013","unstructured":"Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol. 2013;2(2):38\u201343. https:\/\/doi.org\/10.5527\/wjn.v2.i2.38.","journal-title":"World J Nephrol"},{"issue":"3","key":"2692_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13896","volume":"9","author":"D Kamei","year":"2023","unstructured":"Kamei D, Nagano M, Takagaki T, Sakamoto T, Tsuchiya K. Comparison between liquid chromatography\/tandem mass spectroscopy and a novel latex agglutination method for measurement of hepcidin-25 concentrations in dialysis patients with renal anemia: a multicenter study. Heliyon. 2023;9(3): e13896. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13896.","journal-title":"Heliyon"},{"issue":"Suppl 1","key":"2692_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1744-9987.12294","volume":"19","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Kawanishi H, Suzuki K, Nakai S, Tsuchida K, Tabei K, et al. Japanese society for dialysis therapy clinical guideline for \"Maintenance hemodialysis: hemodialysis prescriptions. Ther Apher Dial. 2015;19(Suppl 1):67\u201392. https:\/\/doi.org\/10.1111\/1744-9987.12294.","journal-title":"Ther Apher Dial"},{"key":"2692_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-017-0114-y","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, et al. Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Renal Replace Therapy. 2017. https:\/\/doi.org\/10.1186\/s41100-017-0114-y.","journal-title":"Renal Replace Therapy."},{"issue":"9","key":"2692_CR15","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434\u201343. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.01.014.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2692_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3945\/an.116.013961","volume":"8","author":"V Sangkhae","year":"2017","unstructured":"Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126\u201336. https:\/\/doi.org\/10.3945\/an.116.013961.","journal-title":"Adv Nutr"},{"issue":"9","key":"2692_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","volume":"12","author":"K van der Putten","year":"2010","unstructured":"van der Putten K, Jie KE, van den Broek D, Kraaijenhagen RJ, Laarakkers C, Swinkels DW, et al. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients. Eur J Heart Fail. 2010;12(9):943\u201350. https:\/\/doi.org\/10.1093\/eurjhf\/hfq099.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"2692_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1373\/clinchem.2018.297242","volume":"65","author":"TB Grammer","year":"2019","unstructured":"Grammer TB, Kleber ME, Silbernagel G, Pilz S, Scharnagl H, Tomaschitz A, et al. Iron metabolism, hepcidin, and mortality (the Ludwigshafen risk and cardiovascular health study). Clin Chem. 2019;65(7):849\u201361. https:\/\/doi.org\/10.1373\/clinchem.2018.297242.","journal-title":"Clin Chem"},{"issue":"6","key":"2692_CR19","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1210\/en.2006-1331","volume":"148","author":"U Merle","year":"2007","unstructured":"Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology. 2007;148(6):2663\u20138. https:\/\/doi.org\/10.1210\/en.2006-1331.","journal-title":"Endocrinology"},{"issue":"9","key":"2692_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025324","volume":"6","author":"H Ding","year":"2011","unstructured":"Ding H, Yan C, Feng Y, Zhu H, Wang H, Liu Z, et al. Hepcidin is involved in iron regulation in the ischemic brain. PLoS ONE. 2011;6(9): e25324. https:\/\/doi.org\/10.1371\/journal.pone.0025324.","journal-title":"PLoS ONE"},{"key":"2692_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19804","author":"S Lakhal-Littleton","year":"2016","unstructured":"Lakhal-Littleton S, Wolna M, Chung YJ, Christian HC, Heather LC, Brescia M, et al. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.19804.","journal-title":"Elife"},{"issue":"1","key":"2692_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1745-6673-9-11","volume":"9","author":"YP Hsieh","year":"2014","unstructured":"Hsieh YP, Huang CH, Lee CY, Lin CY, Chang CC. Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes. J Occup Med Toxicol. 2014;9(1):11. https:\/\/doi.org\/10.1186\/1745-6673-9-11.","journal-title":"J Occup Med Toxicol"},{"issue":"4","key":"2692_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11248-011-9582-y","volume":"21","author":"L Zhang","year":"2012","unstructured":"Zhang L, Lu D, Zhang W, Quan X, Dong W, Xu Y, et al. Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice. Transgenic Res. 2012;21(4):867\u201378. https:\/\/doi.org\/10.1007\/s11248-011-9582-y.","journal-title":"Transgenic Res"},{"issue":"3","key":"2692_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1042\/BJ20110225","volume":"437","author":"ML Island","year":"2011","unstructured":"Island ML, Fatih N, Leroyer P, Brissot P, Loreal O. GATA-4 transcription factor regulates hepatic hepcidin expression. Biochem J. 2011;437(3):477\u201382. https:\/\/doi.org\/10.1042\/BJ20110225.","journal-title":"Biochem J"},{"issue":"1","key":"2692_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12967-018-1399-5","volume":"16","author":"D Vela","year":"2018","unstructured":"Vela D. Hepcidin, an emerging and important player in brain iron homeostasis. J Transl Med. 2018;16(1):25. https:\/\/doi.org\/10.1186\/s12967-018-1399-5.","journal-title":"J Transl Med"},{"issue":"1","key":"2692_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12933-024-02377-x","volume":"23","author":"A Mantovani","year":"2024","unstructured":"Mantovani A, Busti F, Borella N, Scoccia E, Pecoraro B, Sani E, et al. Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovasc Diabetol. 2024;23(1):305\u201316. https:\/\/doi.org\/10.1186\/s12933-024-02377-x.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02692-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02692-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:52Z","timestamp":1761708832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02692-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02692-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Original article has been corrected to update Table\n                      \n                      .","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animals rights"}}]}}